Amiko and Luz Saúde Partner to Upgrade Respiratory Care
London/Lisbon, UK/PT, 03 July 2018 – Amiko Digital Health Limited (Amiko), a company that develops advanced medication sensor technologies and digital therapeutic solutions
Amiko and Sanner announce strategic partnership
Sanner and Amiko partner to develop digital solutions for true medication adherence Bensheim/Germany, London/UK, 13 February 2018 – How can artificial intelligence, drug
Amiko receives CE mark for three novel inhaler sensors
Amiko receives CE mark for use of the Respiro Platform with Teva’s Spiromax® Inhaler, Chiesi’s Nexthaler® inhaler and GlaxoSmithKline’s Ellipta® inhaler London,
New funding to expand Respiro
Amiko Digital Health announces the investment from strategic investors Sanner and Breed Reply London, UK. Dec. 18, 2017 — Amiko Digital Health Limited (Amiko),
1st prize – IBM Watson AI XPRIZE’s Milestone awards
Amiko’s Respiro awarded with the 1st prize at the IBM Watson AI XPRIZE’s annual Milestone Awards Los Angeles, US. Dec. 8, 2017 — Amiko Digital Health Limited (Amiko),